Literature DB >> 30206796

Barriers to the identification of familial hypercholesterolemia among primary care providers.

John Zimmerman1, Daniel Duprez2, Patricia McCarthy Veach3, Heather A Zierhut4.   

Abstract

Familial hypercholesterolemia (FH) is severely underdiagnosed in the USA. Primary care providers are well-positioned to identify FH cases; however, universal FH screening is not routinely implemented in practice. The aim of the present study was to identify perceived barriers to FH screening among primary care physicians in Minnesota. A questionnaire assessed FH screening practices, knowledge, and perceived barriers to FH screening. The questionnaire, sent electronically to internal and family medicine physicians in Minnesota (N = 1932) yielded a conservative estimated response rate of 9% (N = 173). Although 92% of participants reported themselves responsible for identifying individuals with FH, 30% did not routinely perform screening in practice. Only 50% of participants were able to correctly identify the risk of FH to first-degree relatives of individuals with FH. Challenges incorporating lipid and family history data was the most frequently endorsed barrier to FH screening (34%). A majority of participants endorsed a clinical decision support system that flags individuals at high risk for FH (62%) and an algorithm with cholesterol levels and lipid disorders (56%) as means of facilitating FH screening. Although the generalizability of the findings is unknown, the results underscore the need for increased provider education regarding FH and suggest an FH screening strategy incorporating a clinical decision support system, screening algorithm, and support from other healthcare providers.

Entities:  

Keywords:  Cholesterol screening; Familial hypercholesterolemia; Heart disease; Hypercholesterolemia; Provider education; Universal screening

Year:  2018        PMID: 30206796      PMCID: PMC6435775          DOI: 10.1007/s12687-018-0383-3

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  5 in total

1.  Understanding Implementation Challenges to Genetic Testing for Familial Hypercholesterolemia in the United States.

Authors:  Rachele M Hendricks-Sturrup; Christine Y Lu
Journal:  J Pers Med       Date:  2019-02-01

Review 2.  Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review.

Authors:  Rachele M Hendricks-Sturrup; Kathleen M Mazor; Amy C Sturm; Christine Y Lu
Journal:  J Pers Med       Date:  2019-07-01

Review 3.  Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care.

Authors:  Rodrigo Alonso; Leopoldo Perez de Isla; Ovidio Muñiz-Grijalvo; Pedro Mata
Journal:  Vasc Health Risk Manag       Date:  2020-01-09

4.  Patient experiences align with the familial hypercholesterolemia global call to action.

Authors:  Laney K Jones; Nicole Walters; Andrew Brangan; Catherine D Ahmed; Katherine A Wilemon; Gemme Campbell-Salome; Alanna K Rahm; Samuel S Gidding; Amy C Sturm
Journal:  Am J Prev Cardiol       Date:  2022-04-18

5.  Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.

Authors:  Laney K Jones; Nicole Walters; Andrew Brangan; Catherine D Ahmed; Michael Gatusky; Gemme Campbell-Salome; Ilene G Ladd; Amanda Sheldon; Samuel S Gidding; Mary P McGowan; Alanna K Rahm; Amy C Sturm
Journal:  J Pers Med       Date:  2021-06-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.